FARMINGDALE, N.Y. & WINOOSKI, Vt.--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) announced today a co-marketing partnership between its Enzo Life Sciences subsidiary, a world leader in non-radioactive probe technology, and BioTek Instruments, a privately held global leader in the development, manufacture and sale of microplate instrumentation for drug discovery and life science applications, involving powerful, integrated solutions for high throughput live cell analysis.
